Episodic ataxia type 2: genes and variants

Explore variant evidence for Episodic ataxia type 2 across 3 analyzed proteins (CACNA1A, KCNA1, SCN2A). Linked ClinVar records include 136 pathogenic or likely pathogenic variants, 1,064 variants of uncertain significance and 286 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.

Data updated 2026-11-05. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Episodic ataxia type 2

Where Episodic ataxia type 2 variants cluster

ClinVar pathogenic and likely pathogenic variants linked to Episodic ataxia type 2

VariantPositionProtein partClinical label
KCNA1 T226R226Segment S2Pathogenic / likely pathogenic (★★)
KCNA1 T226M226Segment S2Pathogenic / likely pathogenic (★★)
KCNA1 P405L405Segment S6Pathogenic / likely pathogenic (★★)
KCNA1 P405A405Segment S6Pathogenic / likely pathogenic (★★)
CACNA1A D302N302IPathogenic / likely pathogenic (★★)
CACNA1A R1348W1348IIIPathogenic / likely pathogenic (★★)
CACNA1A R1358W1358IIIPathogenic / likely pathogenic (★★)
CACNA1A V1392M1392IIIPathogenic / likely pathogenic (★★)
CACNA1A R1660H1660IVPathogenic / likely pathogenic (★★)
CACNA1A R1660C1660IVPathogenic / likely pathogenic (★★)
CACNA1A R1666W1666IVPathogenic / likely pathogenic (★★)
CACNA1A I1708T1708IVPathogenic / likely pathogenic (★★)
CACNA1A Y62H62CytoplasmicPathogenic / likely pathogenic (★★)
CACNA1A Y62C62CytoplasmicPathogenic / likely pathogenic (★★)
CACNA1A S218L218IPathogenic / likely pathogenic (★★)
CACNA1A I711M711IIPathogenic / likely pathogenic (★★)
CACNA1A R1348Q1348IIIPathogenic / likely pathogenic (★★)
CACNA1A V1392A1392IIIPathogenic / likely pathogenic (★★)
CACNA1A R1666P1666IVPathogenic / likely pathogenic (★★)
CACNA1A R1666Q1666IVPathogenic / likely pathogenic (★★)
CACNA1A I1809L1809IVPathogenic / likely pathogenic (★★)
KCNA1 I262T262Segment S3Pathogenic / likely pathogenic (★★)
KCNA1 I314T314S4-S5 linkerPathogenic / likely pathogenic (★★)
KCNA1 V404I404Segment S6Pathogenic / likely pathogenic (★★)
CACNA1A E147K147IPathogenic / likely pathogenic (★★)
CACNA1A G297R297IPathogenic / likely pathogenic (★★)
CACNA1A T500M500IIPathogenic / likely pathogenic (★★)
CACNA1A E532K532IIPathogenic / likely pathogenic (★★)
CACNA1A G539R539IIPathogenic / likely pathogenic (★★)
CACNA1A A628T628IIPathogenic / likely pathogenic (★★)
CACNA1A R1345Q1345IIIPathogenic / likely pathogenic (★★)
CACNA1A R1351Q1351IIIPathogenic / likely pathogenic (★★)
CACNA1A G1754R1754IVPathogenic / likely pathogenic (★★)
CACNA1A S1798L1798IVPathogenic / likely pathogenic (★★)
CACNA1A V1808I1808IVPathogenic / likely pathogenic (★★)
SCN2A R937H937IIPathogenic / likely pathogenic (★★)
CACNA1A V215A215IPathogenic / likely pathogenic (★★)
CACNA1A D302H302IPathogenic / likely pathogenic (★★)
CACNA1A E667K667IIPathogenic / likely pathogenic (★★)
CACNA1A I711V711IIPathogenic / likely pathogenic (★★)
CACNA1A V713M713IIPathogenic / likely pathogenic (★★)
CACNA1A P1352L1352IIIPathogenic / likely pathogenic (★★)
CACNA1A T1355N1355IIIPathogenic / likely pathogenic (★★)
CACNA1A R1663Q1663IVPathogenic / likely pathogenic (★★)
CACNA1A S1798P1798IVPathogenic / likely pathogenic (★★)
CACNA1A A1807S1807IVPathogenic / likely pathogenic (★★)
KCNA1 L305F305Segment S4Pathogenic / likely pathogenic (★★)
KCNA1 G396V396Segment S6Pathogenic / likely pathogenic (★★)
CACNA1A P202L202IPathogenic / likely pathogenic (★★)
CACNA1A V1455M1455IIIPathogenic / likely pathogenic (★★)
CACNA1A S1468L1468IIIPathogenic / likely pathogenic (★★)
KCNA1 V174F174Segment S1Pathogenic / likely pathogenic (★★)
CACNA1A E101K101IPathogenic / likely pathogenic (★★)
CACNA1A R192Q192IPathogenic / likely pathogenic (★★)
CACNA1A H253Y253IPathogenic / likely pathogenic (★★)
CACNA1A C272Y272IPathogenic / likely pathogenic (★★)
CACNA1A R279C279IPathogenic / likely pathogenic (★★)
CACNA1A G293R293IPathogenic / likely pathogenic (★★)
CACNA1A G676R676IIPathogenic / likely pathogenic (★★)
CACNA1A E1263K1263IIIPathogenic / likely pathogenic (★★)

Showing 60 of 136.

Uncertain variants prioritized for review in Episodic ataxia type 2

VariantPositionProtein partClinical labelEvidence
KCNA1 G376R376IntramembraneConflicting reports (★)+7: G376S at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.963
KCNA1 E325K325Segment S5Uncertain (★)+7: 3 other pathogenic changes within 3 positions; E325D at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.938
KCNA1 P403T403Segment S6Uncertain (★)+7: 4 other pathogenic changes within 3 positions; P403S at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.891
CACNA1A R1672H1672IVConflicting reports (★)+6: R1672P at the same position is pathogenic; REVEL 0.954
CACNA1A R1678C1678IVConflicting reports (★)+6: 2 other pathogenic changes within 3 positions; R1678S at the same position is pathogenic; REVEL 0.959
CACNA1A R1739W1739IVConflicting reports (★)+6: R1739P at the same position is pathogenic; REVEL 0.933
CACNA1A V1392L1392IIIConflicting reports (★)+6: 3 other pathogenic changes within 3 positions; V1392A at the same position is pathogenic; REVEL 0.823
CACNA1A R192W192IConflicting reports (★)+6: 2 other pathogenic changes within 3 positions; R192Q at the same position is pathogenic; REVEL 0.897
CACNA1A V1806I1806IVUncertain (★)+6: 6 other pathogenic changes within 3 positions; V1806A at the same position is pathogenic; REVEL 0.855
CACNA1A A1391S1391IIIUncertain (★)+6: 3 other pathogenic changes within 3 positions; A1391V at the same position is pathogenic; REVEL 0.829

Which prediction tools work for Episodic ataxia type 2

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to Episodic ataxia type 2

Frequently asked questions

Which genes have records linked to Episodic ataxia type 2?

This view contains 3 analyzed proteins: CACNA1A, KCNA1, SCN2A. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 136 pathogenic or likely pathogenic variants, 1,064 variants of uncertain significance and 286 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 10 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 1,601 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center